کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
4262431 | 1284605 | 2005 | 4 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
A Prospective, Randomized, Multicenter Study Evaluating the Safety and Efficacy of Two Dosing Regimens of Daclizumab Compared to No Antibody Induction in Simultaneous Kidney-Pancreas Transplantation: Results at 3 Years
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
عمل جراحی
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: A Prospective, Randomized, Multicenter Study Evaluating the Safety and Efficacy of Two Dosing Regimens of Daclizumab Compared to No Antibody Induction in Simultaneous Kidney-Pancreas Transplantation: Results at 3 Years A Prospective, Randomized, Multicenter Study Evaluating the Safety and Efficacy of Two Dosing Regimens of Daclizumab Compared to No Antibody Induction in Simultaneous Kidney-Pancreas Transplantation: Results at 3 Years](/preview/png/4262431.png)
چکیده انگلیسی
The alternative 2-dose regimen of daclizumab was as safe and effective as the conventional 5-dose regimen compared to no antibody induction in SKPT patients, but no long-term benefits were noted.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Transplantation Proceedings - Volume 37, Issue 8, October 2005, Pages 3531-3534
Journal: Transplantation Proceedings - Volume 37, Issue 8, October 2005, Pages 3531-3534
نویسندگان
R.J. Stratta, R.R. Alloway, A. Lo, E.E. Hodge, Pancreas Investigators Vital Outcomes Trial (PIVOT) Study Group Pancreas Investigators Vital Outcomes Trial (PIVOT) Study Group,